SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-01-502176
Filing Date
2001-07-27
Accepted
2001-07-27 00:00:00
Documents
5
Period of Report
2001-07-12
Items
Item 2: Acquisition or disposition of assets
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. b40128age8-k.txt 8-K 8529
2 CONSENT OF ARTHUR ANDERSEN LLP b40128agex23-1.txt EX-23.1 668
3 PRESS RELEASE DATED 7/12/01 b40128agex99-1.txt EX-99.1 4620
4 FINANCIAL STATEMENTS OF ARONEX PHARMACEUTICALS b40128agex99-2.txt EX-99.2 148963
5 UNAUDITED PRO FORMA FINANCIAL INFORMATION b40128agex99-3.txt EX-99.3 26298
  Complete submission text file 0000950135-01-502176.txt   191144
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 1690211
SIC: 2836 Biological Products, (No Diagnostic Substances)